← Leaderboards
Scott A Tomlins
University Of Michigan At Ann Arbor
$2,737,217
Attributed
$3,865,011
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2014–18$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$3,865,011 · 3
By mechanism
R01$2,719,550 · 2
U01$1,145,461 · 1
Top collaborators
- William E Rainey3 shared
- Arul M Chinnaiyan2 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Arul M Chinnaiyan$35,112,976
- Adina F Turcu$6,120,067
- Charles F Burant$27,360,950
- Tobias Else$2,122,919
- James Brian Byrd$2,510,241
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseMutationTissuesLeadGeneticIn VitroPublic Health RelevanceProstateCancer PatientGenesPreventTranscriptomicsNext Generation SequencingCastration Resistant Prostate CancerMalignant Neoplasm Of ProstateOutcome ForecastMetastatic Prostate CancerAmericanInhibitor/AntagonistAutomobile DrivingChemotherapyIncidenceAntiandrogen TherapyGene Expression
Grant awards (10)
Exploiting drivers of androgen receptor signaling negative prostate cancer for pr$321,625
R01 · FY2018 · CA · contact PI
Discovery and qualification of transcriptomic biomarkers for the early detection of aggressive prostate cancer$573,018
U01 · FY2017 · CA
Adrenal Origins of Aldosterone Excess$451,469
R01 · FY2017 · DK
Exploiting drivers of androgen receptor signaling negative prostate cancer for pr$321,625
R01 · FY2017 · CA · contact PI
Adrenal Origins of Aldosterone Excess$193,863
R01 · FY2017 · DK
Discovery and qualification of transcriptomic biomarkers for the early detection of aggressive prostate cancer$572,443
U01 · FY2016 · CA
Adrenal Origins of Aldosterone Excess$464,795
R01 · FY2016 · DK
Exploiting drivers of androgen receptor signaling negative prostate cancer for pr$321,625
R01 · FY2016 · CA · contact PI
Exploiting drivers of androgen receptor signaling negative prostate cancer for pr$321,885
R01 · FY2015 · CA · contact PI
Exploiting drivers of androgen receptor signaling negative prostate cancer for pr$322,663
R01 · FY2014 · CA · contact PI